ロード中...
Monitor Therapeutic Response of Human Ovarian Cancer to 17-DMAG by Non-invasive PET imaging with (64)Cu-DOTA-Trastuzumab
PURPOSES: 17-DMAG, a heat shock protein 90 (Hsp90) inhibitor, has been intensively investigated for cancer therapy and is undergoing clinical trials. Human epidermal growth factor receptor 2 (HER-2) is one of the client proteins of Hsp90 and its expression is decreased upon 17-DMAG treatment. In thi...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3596115/ https://ncbi.nlm.nih.gov/pubmed/19440708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-009-1158-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|